Singaporean investor has failed to provide alternate strategy for Cromwell, despite heavy criticism and bid to win board seats, according to a proxy adviser.
Trade tensions may tempt China to accelerate development of African iron ore, but analysts say it will have little impact on Australia's market share and prices.
AMP suitors will face a tough time untangling the complex and interconnected parts of the wealth manager's sprawling business, plus the enormous costs of separation.
Zhong Shanshan's 84 per cent post-IPO stake in Nongfu is valued at $36 billion, putting his net worth at $52 billion.
Big four consultancy Deloitte has ended its 20 per cent COVID-19 pay cuts a month early, with staff told better-than-expected revenue means their salaries would return...
PointsBet's capital raising is a model of fairness for existing investors. Now it needs to pull off huge growth ambitions shared by none other than Michael...
International research, led by Australia, has opened up a whole class of anti-inflammatory drugs for the treatment of COVID-19.
On Thursday's $3.73 share price, John Guscic would make roughly $1.95 million off the 3 million options whose conditions he has already met.
The blocks are flying at Xero with a $100 million parcel of shares changing hands on Thursday.
The troubled manufacturer's advisers have nearly completed their investigations, with a final report into a $60 million stock bungle due in coming weeks.